Company Overview of Valentis Inc.
As of July 13, 2007, Valentis Inc. was acquired by Urigen N.A., Inc., in a reverse merger transaction. Valentis, Inc. does not have significant operations. Previously, the company was engaged in the development of products for peripheral artery disease. Valentis, Inc. was founded in 1992 and is headquartered in Burlingame, California.
533 Airport Boulevard
Burlingame, CA 94010
Founded in 1992
Key Executives for Valentis Inc.
Valentis Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Abbott Chemicals, Inc.||United States|
|BioSeek, Inc.||United States|
|LifeSpan BioSciences, Inc.||United States|
|Wockhardt USA, Inc.||United States|
|Cirrus Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Adelphi, MD | University of Maryland University CollegePosted: Jun 12
- Milwaukee, WI | Robert W. BairdPosted: Apr 19
- Dallas, TX | Santa Cruz BiotechnologyPosted: Jun 11
- Greenfield, IN | CovancePosted: May 31
Sponsored Financial Commentaries
To contact Valentis Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.